BPC-157 stability concerns — oral, injectable, and what degrades it

There is significant debate about BPC-157 stability, particularly regarding oral versus injectable forms and what causes degradation. The community has documented important distinctions between these routes and degradation mechanisms.

Chemical stability basics:
BPC-157 is a pentadecapeptide — 15 amino acids long. Like all peptides, it is susceptible to degradation from heat, light, pH extremes, and bacterial contamination. However, BPC-157 is notably more stable than many peptides at physiological pH, which is part of why the oral route has received research attention.

Injectable BPC-157:
Once reconstituted with bacteriostatic water, injectable BPC-157 should be refrigerated and used within 2-3 weeks. Some researchers report stability up to 4 weeks, but degradation accelerates after the 2-week mark. Signs of degradation include cloudiness, particulate matter, or unusual color changes. If reconstituted BPC-157 looks different from the initial mixture, it should be discarded.

Oral BPC-157 — the controversy:
BPC-157 was originally isolated from gastric juice, which is why the oral administration route receives research attention. The argument is that it is naturally stable in the acidic gastric environment. Published animal studies have shown oral BPC-157 to be effective for GI-related research (gut healing, inflammatory bowel conditions), and there is evidence it survives gastric acid to some degree.

However, there are important caveats. Oral bioavailability for systemic effects (joints, tendons, etc.) is likely much lower than injectable administration. The published studies showing systemic effects from oral BPC-157 used doses significantly higher than typical injectable doses. Community reports are mixed — many researchers report oral BPC-157 is effective for gut-specific research but less noticeable for systemic applications.

What degrades BPC-157 fastest:
Temperature above 37°C / 98°F — reconstituted BPC-157 should not be left at room temperature for extended periods. Direct sunlight or UV exposure accelerates degradation. Repeated freeze-thaw cycles should be avoided — if reconstituted peptide is frozen, it should only be thawed once. Contamination from non-sterile technique is a major factor — always use alcohol swabs, never touch needle tips, and use BAC water (not sterile water, which lacks the bacteriostatic preservative).

Storage recommendations:
Lyophilized (powder): Freezer for long-term, fridge for short-term. Stable for months to years when properly stored. Reconstituted: Refrigerator only. Use within 14-21 days. Do not freeze reconstituted BPC-157. Oral capsules/tablets: Follow manufacturer storage guidelines. Keep away from moisture and heat.

The arginine salt form:
Some vendors offer BPC-157 as the arginine salt rather than the acetate salt. The arginine salt is reported to have better water solubility and potentially better stability. Both forms should be biologically equivalent once in solution, but the arginine salt may dissolve more readily during reconstitution.

When running BPC-157 research, documenting storage conditions alongside results is important. This kind of detail helps the community understand when suboptimal results might be a storage issue versus a product quality issue.